Nadia Dac
Corporate Officer/Principal chez OMEROS CORPORATION
Postes actifs de Nadia Dac
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| OMEROS CORPORATION | Corporate Officer/Principal | 26/01/2021 | - |
Historique de carrière de Nadia Dac
Anciens postes connus de Nadia Dac
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALDER BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 08/04/2019 | 01/06/2020 |
| ABBVIE INC. | Corporate Officer/Principal | 01/12/2014 | 01/03/2019 |
| AUXILIUM PHARMACEUTICALS, INC. | Sales & Marketing | 01/05/2013 | 01/09/2014 |
| NOVARTIS AG | Corporate Officer/Principal | 01/01/2009 | 01/01/2013 |
Formation de Nadia Dac
| Rutgers State University of New Jersey | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| Suisse | 2 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Sales & Marketing | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| OMEROS CORPORATION | Health Technology |
| ABBVIE INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| Entreprise privées | 2 |
|---|---|
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
Auxilium Pharmaceuticals LLC
 Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Auxilium Pharmaceuticals LLC develops and markets pharmaceutical products. It specializes in men's healthcare area and has product portfolio and pipeline in orthopedics, dermatology and other therapeutic areas. The firm products include edex, Osbon, ErecAid, STENDRA, TESTOPEL, XIAFLEX and Testim. The company was founded by Gerri A. Henwood and Jane Holmes Hollingsworth in 1999 and is headquartered in Chesterbrook, PA. | Health Technology |
